RTICBM-189 (RTICBM189) is brain penetrant and allosteric modulator of the cannabinoid 1 (CB1) receptor (pIC50 = 7.54 in Ca2+ mobilization assay). It lessens the resumption of drug-seeking behavior.
Physicochemical Properties
| Molecular Formula | C15H14CL2N2O |
| Molecular Weight | 309.19 |
| Exact Mass | 308.05 |
| Elemental Analysis | C, 58.27; H, 4.56; Cl, 22.93; N, 9.06; O, 5.17 |
| CAS # | 551909-15-0 |
| PubChem CID | 5076367 |
| Appearance | White to off-white solid powder |
| LogP | 4.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 20 |
| Complexity | 306 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | PPKIPROVSKBYAT-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C15H14Cl2N2O/c16-12-4-6-14(7-5-12)19-15(20)18-9-8-11-2-1-3-13(17)10-11/h1-7,10H,8-9H2,(H2,18,19,20) |
| Chemical Name | 1-(4-chlorophenyl)-3-[2-(3-chlorophenyl)ethyl]urea |
| Synonyms | RTICBM189; RTICBM 189; RTICBM-189 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | CB1 ( pIC50 = 7.54 ); hCB1 ( pIC50 = 5.29 ); mCB1 ( pIC50 = 6.25 ) | |
| ln Vitro |
|
|
| ln Vivo |
|
|
| Animal Protocol |
Adult male Sprague-Dawley rats weighing 280-300 g 10 mg/kg IP |
|
| References |
[1]. Development of 3-(4-Chlorophenyl)-1-(phenethyl)urea Analogues as Allosteric Modulators of the Cannabinoid Type-1 Receptor: RTICBM-189 is Brain Penetrant and Attenuates Reinstatement of Cocaine-Seeking Behavior [published online ahead of print, 2021 Dec 20]. J Med Chem. 2021;10.1021/acs.jmedchem.1c01432. |
Solubility Data
| Solubility (In Vitro) |
DMSO: 62~100 mg/mL (200.5~323.4 mM) Ethanol: ~3 mg/mL |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (8.09 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. Solubility in Formulation 2: 2.08 mg/mL (6.73 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.2343 mL | 16.1713 mL | 32.3426 mL | |
| 5 mM | 0.6469 mL | 3.2343 mL | 6.4685 mL | |
| 10 mM | 0.3234 mL | 1.6171 mL | 3.2343 mL |